Originally posted in the Journal of Animal Science and Biotechnology 2013, 4:37. doi:10.1186/2049-1891-4-37 Abstract In 2012, genetically engineered (GE) crops were grown by 17.3 million farmers on over 170 million hectares. Over 70% of ... GMOAnswers, 1 hour ago
1 images for "biotechnology regulatory authority of india b"
- MMRGlobal, Inc. (OTCQB: MMRF) (the "Company") today announced that for the first time in two years, the Company will not be requesting an increase in its authorized shares of common stock going into its Annual Meeting scheduled for July 16, 2014.ADVFN UK, 2 months ago MMRGLOBAL : Announces No Increase in Authorized Shares Due to Record Sales & Licensing Revenues 4 Traders, 2 months ago Annual Financial Report MoneyAM, 1 month ago Orphan Drugs for CNS Diseases: R&D and Market 2014-2024 Tamar Securities, 1 month ago
More from: Town Hall, Town Hall...and 30 other sources
Welcome to Science Saturday, where the Overnight News Digest crew, consisting of founder Magnifico, regular editors maggiejean, wader, Man Oh Man, side pocket, rfall, and JML9999, alumni editors palantir, Bentliberal, Oke, jlms qkw, Interceptor7, ...Daily Kos, 6 days ago
Note: As part of his investigation, the author has shared the contents of this article along with additional materials with the United States Securities and Exchange Commission. Note: Additional links and information on these topics has been and ...Nasdaq, 3 weeks ago
Countercurrents.org The proposal to hand back some decision powers to member states of the European Union regarding GMO approvals is currently being discussed (1). It will be voted on by member states on 12 June. According to Corporate Europe ...Counter Currents, 1 month ago Monsanto, Syngenta, Pioneer et al.: Through Political Cooptation and Corruption, the GMO Biotech Sector is Kicking Open the Door to Europe RINF.com, 1 month ago
GENEREX BIOTECHNOLOGY : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
As used herein, the terms the "Company," "Generex," "we," "us," or "our" refer to Generex Biotechnology Corporation , a Delaware corporation. The following discussion and analysis by management provides information with respect to our financial ...4 Traders, 1 month ago GENEREX BIOTECHNOLOGY CORP - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations HispanicBusiness.com, 1 month ago
IMS HEALTH HOLDINGS, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Background We are a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. We have one of the largest and most comprehensive ...TMC Net, 2 days ago
Oregonians will have the opportunity to vote this November on the consumer's right to know what is in their food thanks to the Oregon Right to Know campaign which gathered 156,390 signatures, 118,780 of which were certified on Wednesday by the ...Daily Kos, 5 days ago
John Lothian Newsletter: ICE's Swap Execution Facility Head Barsoom to Leave in August; SFO gears up for UK forex trading probe; Barclays Dark Pool Drew Early Alarms on Fast Trading
First Read The Eagle Has Arrived Jeremie Bacon Orc Group Howdy! My name is Jeremie Bacon. Im the president of Orc Group's North and South American operations and am thrilled to be the guest editor of the John Lothian Newsletter this week. ...John Lothian Newsletter, 1 week ago
Stora Enso CEO Jouko Karvinen and the new Stora Enso CE.. 10:59 - Stora Enso's NRI in second quarter 2014 have EUR 106 mi.. 15 Jul - Stora Enso shares converted Significant operational earnings improvement continues; fixed cost reduction ...EuroInvestor, 1 week ago
on your WebpageAdd Widget >Get your members hooked!